InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,766.20
(
0.94%
)
US TECH 100
19,638.00
(
1.02%
)
Dow Jones
42,096.86
(
0.72%
)
Brent Oil
76.07
(
1.26%
)
Bitcoin
69,976.55
(
3.18%
)
Post# of 346543
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

CuresForHumanity

Send PM Follow Ignore
Followers 14
Posts 608
Boards Moderated 0
Alias Born 06/05/2015

CuresForHumanity

Re: None

Tuesday, 10/11/2016 3:02:38 PM

Tuesday, October 11, 2016 3:02:38 PM

Post# of 346543
My first quick opinion on yesterday's PR is kudos to the company for getting the resources to determine beta-2 GP1 as an important biomarker.

Additional questions and thoughts:

1. Why did they break out the range between 200 and 240 vs greater than 200?

2. Are they in FDA initiation for a biomarker qualification submission?

3. It would be nice to see a deep dive break out of ecog 0 vs 1 vs Bavi/doce vs doce vs alternative drug treatments/ trials patients sought during the trial vs beta 2 GP1 vs patient geographics and how all of that might have effected MOS. Was or will any of that info be prepared?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM

Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM

North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM

Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Start posting your company's news
Only $200 per official company press release!